102 related articles for article (PubMed ID: 16682681)
1. Voglibose inhibits postprandial hypotension in neurologic disorders and elderly people.
Maruta T; Komai K; Takamori M; Yamada M
Neurology; 2006 May; 66(9):1432-4. PubMed ID: 16682681
[TBL] [Abstract][Full Text] [Related]
2. Acarbose, an alpha-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure.
Shibao C; Gamboa A; Diedrich A; Dossett C; Choi L; Farley G; Biaggioni I
Hypertension; 2007 Jul; 50(1):54-61. PubMed ID: 17515447
[TBL] [Abstract][Full Text] [Related]
3. Role of intestinal peptides and the autonomic nervous system in postprandial hypotension in patients with multiple system atrophy.
Fukushima T; Asahina M; Fujinuma Y; Yamanaka Y; Katagiri A; Mori M; Kuwabara S
J Neurol; 2013 Feb; 260(2):475-83. PubMed ID: 22983428
[TBL] [Abstract][Full Text] [Related]
4. Effects of changeover from voglibose to acarbose on postprandial triglycerides in type 2 diabetes mellitus patients.
Matsumura M; Monden T; Miyashita Y; Kawagoe Y; Shimizu H; Nakatani Y; Domeki N; Yanagi K; Ikeda S; Kasai K
Adv Ther; 2009 Jun; 26(6):660-6. PubMed ID: 19568704
[TBL] [Abstract][Full Text] [Related]
5. Effect of two alpha-glucosidase inhibitors, voglibose and acarbose, on postprandial hyperglycemia correlates with subjective abdominal symptoms.
Fujisawa T; Ikegami H; Inoue K; Kawabata Y; Ogihara T
Metabolism; 2005 Mar; 54(3):387-90. PubMed ID: 15736118
[TBL] [Abstract][Full Text] [Related]
6. [Postprandial hypotension and autonomic neuropathy in diabetic patients].
Trofimiuk M; Huszno B; Gołkowski F; Szybiński Z
Folia Med Cracov; 2003; 44(1-2):117-28. PubMed ID: 15232893
[TBL] [Abstract][Full Text] [Related]
7. Relationship between gastric emptying and an alpha-glucosidase inhibitor effect on postprandial hyperglycemia in NIDDM patients.
Kawagishi T; Nishizawa Y; Taniwaki H; Tanaka S; Okuno Y; Inaba M; Ishimura E; Emoto M; Morii H
Diabetes Care; 1997 Oct; 20(10):1529-32. PubMed ID: 9314629
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic interaction of vildagliptin and voglibose in Japanese patients with Type 2 diabetes.
Yamaguchi M; Saji T; Mita S; Kulmatycki K; He YL; Furihata K; Sekiguchi K
Int J Clin Pharmacol Ther; 2013 Aug; 51(8):641-51. PubMed ID: 23782587
[TBL] [Abstract][Full Text] [Related]
9. [Voglibose].
Hara T; Hotta N
Nihon Rinsho; 1997 Nov; 55 Suppl():114-9. PubMed ID: 9434453
[No Abstract] [Full Text] [Related]
10. Acarbose, the α-glucosidase inhibitor, attenuates the blood pressure and splanchnic blood flow responses to meal in elderly patients with postprandial hypotension concomitant with abnormal glucose metabolism.
Qiao W; Li J; Li Y; Qian D; Chen L; Wei X; Jin J; Wang Y
Blood Press Monit; 2016 Feb; 21(1):38-42. PubMed ID: 26474001
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of α-glucosidase inhibitors on postprandial plasma glucose and lipid profile in patients with type 2 diabetes under control with insulin lispro mix 50/50.
Kimura T; Suzuki J; Ichikawa M; Imagawa M; Sato S; Fujii M; Zenimaru Y; Inaba S; Takahashi S; Konoshita T; Miyamori I
Diabetes Technol Ther; 2012 Jul; 14(7):545-51. PubMed ID: 22519736
[TBL] [Abstract][Full Text] [Related]
12. Effects of Food Thickeners on the Inhibitory Effect of Voglibose Oral-disintegrating Tablets on Post-prandial Elevation of Blood Sugar Levels.
Tomita T; Goto H; Sumiya K; Yoshida T; Tanaka K; Kohda Y
Yakugaku Zasshi; 2016; 136(8):1171-6. PubMed ID: 27477734
[TBL] [Abstract][Full Text] [Related]
13. Altered venous capacitance as a cause of postprandial hypotension in multiple system atrophy.
Takamori M; Hirayama M; Kobayashi R; Ito H; Mabuchi N; Nakamura T; Hori N; Koike Y; Sobue G
Clin Auton Res; 2007 Feb; 17(1):20-5. PubMed ID: 17139443
[TBL] [Abstract][Full Text] [Related]
14. Mitiglinide/voglibose fixed-dose combination improves postprandial glycemic excursions in Japanese patients with type 2 diabetes mellitus.
Ono Y; Kameda H; Cho KY
Expert Opin Pharmacother; 2013 Mar; 14(4):361-70. PubMed ID: 23414242
[TBL] [Abstract][Full Text] [Related]
15. Effect of the somatostatin analogue SMS-201-995 on the adrenergic response to glucose ingestion in patients with postprandial hypotension.
Hoeldtke RD; Dworkin GE; Gaspar SR; Israel BC; Boden G
Am J Med; 1989 Jun; 86(6 Pt 1):673-7. PubMed ID: 2658575
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological treatment of postprandial hyperglycemia in hypertensive patients with type 2 diabetes mellitus].
Yamada K
Nihon Rinsho; 2003 Jul; 61(7):1219-23. PubMed ID: 12877088
[TBL] [Abstract][Full Text] [Related]
17. [Effects of voglibose, alpha-glucosidase inhibitor in treatment of impaired glucose tolerance].
Nakamura J
Nihon Rinsho; 2005 Feb; 63 Suppl 2():457-61. PubMed ID: 15779422
[No Abstract] [Full Text] [Related]
18. Chronic administration of voglibose, an alpha-glucosidase inhibitor, increases active glucagon-like peptide-1 levels by increasing its secretion and decreasing dipeptidyl peptidase-4 activity in ob/ob mice.
Moritoh Y; Takeuchi K; Hazama M
J Pharmacol Exp Ther; 2009 May; 329(2):669-76. PubMed ID: 19208898
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of Postprandial Hypotension with Acarbose in Older Adults with Type 2 Diabetes Mellitus.
Madden KM; Harris DE; Meneilly GS
J Am Geriatr Soc; 2015 Jul; 63(7):1484-6. PubMed ID: 26189860
[No Abstract] [Full Text] [Related]
20. Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance.
Kawamori R; Tajima N; Iwamoto Y; Kashiwagi A; Shimamoto K; Kaku K;
Lancet; 2009 May; 373(9675):1607-14. PubMed ID: 19395079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]